Cargando…
The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not liver-related but stems from atherosclerotic card...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234007/ https://www.ncbi.nlm.nih.gov/pubmed/34205674 http://dx.doi.org/10.3390/ijms22126627 |
_version_ | 1783713982814617600 |
---|---|
author | Dogru, Teoman Kirik, Ali Gurel, Hasan Rizvi, Ali A. Rizzo, Manfredi Sonmez, Alper |
author_facet | Dogru, Teoman Kirik, Ali Gurel, Hasan Rizvi, Ali A. Rizzo, Manfredi Sonmez, Alper |
author_sort | Dogru, Teoman |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not liver-related but stems from atherosclerotic cardiovascular disease (CVD). The prevalence of NAFLD is on the rise, mainly as a consequence of its close association with two major worldwide epidemics, obesity and type 2 diabetes (T2D). The exact pathogenesis of NAFLD and especially the mechanisms leading to disease progression and CVD have not been completely elucidated. Human fetuin-A (alpha-2-Heremans Schmid glycoprotein), a glycoprotein produced by the liver and abundantly secreted into the circulation appears to play a role in insulin resistance, metabolic syndrome and inflammation. This review discusses the links between NAFLD and CVD by specifically focusing on fetuin-A’s function in the pathogenesis of NAFLD and atherosclerotic CVD. |
format | Online Article Text |
id | pubmed-8234007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82340072021-06-27 The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart Dogru, Teoman Kirik, Ali Gurel, Hasan Rizvi, Ali A. Rizzo, Manfredi Sonmez, Alper Int J Mol Sci Review Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not liver-related but stems from atherosclerotic cardiovascular disease (CVD). The prevalence of NAFLD is on the rise, mainly as a consequence of its close association with two major worldwide epidemics, obesity and type 2 diabetes (T2D). The exact pathogenesis of NAFLD and especially the mechanisms leading to disease progression and CVD have not been completely elucidated. Human fetuin-A (alpha-2-Heremans Schmid glycoprotein), a glycoprotein produced by the liver and abundantly secreted into the circulation appears to play a role in insulin resistance, metabolic syndrome and inflammation. This review discusses the links between NAFLD and CVD by specifically focusing on fetuin-A’s function in the pathogenesis of NAFLD and atherosclerotic CVD. MDPI 2021-06-21 /pmc/articles/PMC8234007/ /pubmed/34205674 http://dx.doi.org/10.3390/ijms22126627 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Dogru, Teoman Kirik, Ali Gurel, Hasan Rizvi, Ali A. Rizzo, Manfredi Sonmez, Alper The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title_full | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title_fullStr | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title_full_unstemmed | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title_short | The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart |
title_sort | evolving role of fetuin-a in nonalcoholic fatty liver disease: an overview from liver to the heart |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234007/ https://www.ncbi.nlm.nih.gov/pubmed/34205674 http://dx.doi.org/10.3390/ijms22126627 |
work_keys_str_mv | AT dogruteoman theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT kirikali theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT gurelhasan theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT rizvialia theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT rizzomanfredi theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT sonmezalper theevolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT dogruteoman evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT kirikali evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT gurelhasan evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT rizvialia evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT rizzomanfredi evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart AT sonmezalper evolvingroleoffetuinainnonalcoholicfattyliverdiseaseanoverviewfromlivertotheheart |